0001209191-23-030202.txt : 20230517 0001209191-23-030202.hdr.sgml : 20230517 20230517163148 ACCESSION NUMBER: 0001209191-23-030202 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lemaitre Dan CENTRAL INDEX KEY: 0001478479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 23932220 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-15 0 0001237831 GLOBUS MEDICAL INC GMED 0001478479 Lemaitre Dan VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 1 0 0 0 0 Class A Common Stock 2023-05-15 4 M 0 1450 23.95 A 12250 D Class A Common Stock 2023-05-15 4 M 0 10500 24.10 A 22750 D Class A Common Stock 2023-05-15 4 M 0 14000 25.52 A 36750 D Class A Common Stock 2023-05-15 4 M 0 17500 26.27 A 54250 D Class A Common Stock 2023-05-15 4 S 0 43450 56.9845 D 10800 D Stock Option (Right to Buy Class A Common Stock) 23.95 2023-05-15 4 M 0 1450 0.00 D 2024-01-23 Class A Common Stock 1450 0 D Stock Option (Right to Buy Class A Common Stock) 24.10 2023-05-15 4 M 0 10500 0.00 D 2025-01-20 Class A Common Stock 10500 0 D Stock Option (Right to Buy Class A Common Stock) 25.52 2023-05-15 4 M 0 14000 0.00 D 2026-01-25 Class A Common Stock 14000 0 D Stock Option (Right to Buy Class A Common Stock) 26.27 2023-05-15 4 M 0 17500 0.00 D 2027-01-30 Class A Common Stock 17500 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.77 to $57.215, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. These options were granted on January 23, 2014 and are fully vested. These options were granted on January 20, 2015 and are fully vested. These options were granted on January 25, 2016 and are fully vested. These options were granted on January 30, 2017 and are fully vested. /s/ Kelly G. Huller, Attorney-in-Fact 2023-05-17